New cancer drug combo trial halted early

NCT ID NCT04914897

Terminated Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding an experimental drug called SAR444245 to other cancer treatments could help control advanced lung cancer or mesothelioma. It involved 106 adults whose cancer had progressed despite prior treatments. The trial was terminated early, and its main goal was to see if the combination could shrink tumors and for how long.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site Number : 0320002

CABA, Buenos Aires, 1430, Argentina
Investigational Site Number : 0360002

Richmond, Victoria, 3121, Australia
Investigational Site Number : 1520001

Santiago, Reg Metropolitana de Santiago, 8420383, Chile
Investigational Site Number : 1520002

Santiago, Reg Metropolitana de Santiago, 7500921, Chile
Investigational Site Number : 1520003

Temuco, 4800827, Chile
Investigational Site Number : 1520004

Santiago, Reg Metropolitana de Santiago, 7500713, Chile
Investigational Site Number : 1520005

Santaigo, Reg Metropolitana de Santiago, 8241470, Chile
Investigational Site Number : 1580002

Tainan, 704, Taiwan
Investigational Site Number : 1580003

Taichung, 404, Taiwan
Investigational Site Number : 1580005

Taipei, Taiwan
Investigational Site Number : 2500001

Saint-Herblain, 44800, France
Investigational Site Number : 2500003

Toulouse, 31059, France
Investigational Site Number : 2500005

Paris, 75018, France
Investigational Site Number : 2500006

Bordeaux, France
Investigational Site Number : 3800001

Rozzano, Milano, 20089, Italy
Investigational Site Number : 3800002

Orbassano, Torino, 10043, Italy
Investigational Site Number : 3800004

Milan, 20133, Italy
Investigational Site Number : 3800005

Aviano (PN), Friuli Venezia Giulia, 33081, Italy
Investigational Site Number : 3800006

Bologna, 40138, Italy
Investigational Site Number : 3800008

Padua, 35128, Italy
Investigational Site Number : 3920001

Sapporo, Hokkaido, 003-0804, Japan
Investigational Site Number : 4100001

Seoul, Seoul-teukbyeolsi, 06351, South Korea
Investigational Site Number : 4100002

Seoul, Seoul-teukbyeolsi, 03080, South Korea
Investigational Site Number : 4100003

Seoul, Seoul-teukbyeolsi, 05505, South Korea
Investigational Site Number : 6160001

Warsaw, Masovian Voivodeship, 02-781, Poland
Investigational Site Number : 6160002

Poznan, Greater Poland Voivodeship, 60-693, Poland
Investigational Site Number : 6160003

Gdansk, Pomeranian Voivodeship, 80-214, Poland
Investigational Site Number : 6160004

Olsztyn, Warmian-Masurian Voivodeship, 10-357, Poland
Investigational Site Number : 7240001

Madrid, 28041, Spain
Investigational Site Number : 7240002

Madrid, 28034, Spain
Investigational Site Number : 7240003

Girona, Girona [Gerona], 17007, Spain
Investigational Site Number : 7240004

Madrid, Madrid, Comunidad de, 28046, Spain
Investigational Site Number : 7240006

Barcelona, Barcelona [Barcelona], 08035, Spain
Thomas Jefferson University - North East Site Number : 8401009

Philadelphia, Pennsylvania, 19114, United States
Thomas Jefferson University Hospital Site Number : 8400009

Philadelphia, Pennsylvania, 19107, United States

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER PLEURAL MESOTHELIOMA